Author

Dagmar Hruska

Observed names: D Hruska, D. Hruschka, D. Hruska

Institution: Klinik Schillerhöhe

Observed institutions: German Cancer Research Center, Klinik Schillerhöhe

OpenAlex ID: A5042310156

Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients.

1991 · M Wolf, M Pritsch, et al. · Journal of Clinical Oncology · 51

Neoadjuvant chemoradiotherapy of stage III non-small-cell lung cancer

2000 · Godehard Friedel, Dagmar Hruska, et al. · Lung Cancer · 27

Topotecan in second-line treatment of small cell lung cancer reduced toxicity with individualized therapy

2000 · R Koschel, R.M Huber, et al. · Lung Cancer · 19

EPICO für die Behandlung des kleinzelligen Bronchialkarzinoms

2009 · P. Drings, H. Bülzebruck, et al. · Onkologie · 10

Open, Randomized, Phase II Study of Single-Agent Gemcitabine and Docetaxel as First- and Second-Line Treatment in Patients with Advanced Non–Small-Cell Lung Cancer

2007 · Christian Manegold, Gabriele Koschel, et al. · Clinical Lung Cancer · 6

Randomized Multicenter Phase II Study of Gemcitabine Versus Docetaxel as First-Line Therapy with Second-Line Crossover in Advanced-Stage Non–Small-Cell Lung Cancer

2005 · Christian Manegold, Lothar Richard Pilz, et al. · Clinical Lung Cancer · 6

Topotecan in Second-Line Therapy of SCLC: Impact on Survival?

2000 · R.M. Huber, U. Gatzemeier, et al. · Onkologie · 6

Gemcitabine (G) followed by 2nd line Docetaxel (D) is feasible in advanced NSCLC: Results from a randomized phase II study

2000 · C Manegold, L Pitz, et al. · Lung Cancer · 5

O-218 Single-agent Gemcitabine (G) and Docetaxel (D) given sequentially every 3 weeks in advanced NSCLC: Final results and quality of life assessment of a randomised phase II study show effective treatment

2003 · Joerg Mezger, Lothar R. Pilz, et al. · Lung Cancer · 1

Inhalt, Vol. 9, Supplement 1, 1986

2009 · P. Drings, D. Hruska, et al. · Onkologie

Hinweise für Autoren

2009 · P. Drings, D. Hruska, et al. · Onkologie

Neoadjuvant chemo-radiation with paclitaxel/carboplatin in stage III non small cell lung [NSCLC] patients

2001 · W. Budach, G. Friedel, et al. · European Journal of Cancer

Single agent gemzar (G) and taxotere (T) given as 1st/2nd line therapy are active in advanced NSCLC: survival data from two randomized phase II studies

2001 · C. Manegold, L.R. Pilz, et al. · European Journal of Cancer

Neoadjuvant chemoradiotherapy for stage III non-small cell lung cancer

1998 · G Friedel, D Hruska, et al. · Lung Cancer

195 Neoadjuvant chemo-radiotherapy in locally advanced non small cell lung cancer

1997 · M. Wolf, G. Friedel, et al. · Lung Cancer

EPICO in the treatment of small cell lung cancer interim analysis

1986 · P. Drings, H. Bülzebruck, et al. · Journal of Cancer Research and Clinical Oncology

Works count: 16

Citation count: 131

H-index: 6

I10-index: 4